



Here is how New York Times Co. (NYT) and Reckitt Benckiser Group PLC (RBGLY) have performed compared to their sector so far this year.
NEW YORK, Aug. 03, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of American Depositary Shares (“ADSs”) of Reckitt Benckiser Group PLC (OTC: RBGLY) between January 13, 2021 and July 28, 2024, both dates inclusive (the “Class Period”), of the important August 4, 2025 lead plaintiff deadline.
Bragar Eagel & Squire, P.C. Litigation Attorney Brandon Walker Encourages Investors Who Suffered Losses In Reckitt (RBGLY) To Contact Him Directly To Discuss Their Options
Does Reckitt Benckiser Group PLC (RBGLY) have what it takes to be a top stock pick for momentum investors? Lets find out.
NEW YORK and NEW ORLEANS, July 22, 2025 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until August 4, 2025 to file lead plaintiff applications in a securities class action lawsuit against Reckitt Benckiser Group PLC (“Reckitt” or the “Company”) (OTC: RBGLY), if they purchased the Company’s American Depositary Shares (“ADSs”) between January 13, 2021 and July 28, 2024, inclusive (th...
Reckitt Benckiser Group has agreed to sell its Essential Home business to private equity firm Advent International for an enterprise value of up to $4.8 billion whilst retaining a 30% equity stake in the divested unit. Reckitt has struggled with direction in recent years, and the sale is part of its strategy to become a […] The post Reckitt Benckiser plans special dividend after home business sale appeared first on UK Investor Magazine.
NEW YORK and NEW ORLEANS, July 15, 2025 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until August 4, 2025 to file lead plaintiff applications in a securities class action lawsuit against Reckitt Benckiser Group PLC (“Reckitt” or the “Company”) (OTC: RBGLY), if they purchased the Company’s American Depositary Shares (“ADSs”) between January 13, 2021 and July 28, 2024, inclusive (th...
NEW YORK, July 05, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of American Depositary Shares (“ADSs”) of Reckitt Benckiser Group PLC (OTC: RBGLY) between January 13, 2021 through July 28, 2024, both dates inclusive (the “Class Period”), of the important August 4, 2025 lead plaintiff deadline.
Here is how Mamas Creations, Inc. (MAMA) and Reckitt Benckiser Group PLC (RBGLY) have performed compared to their sector so far this year.
NEW YORK, June 21, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of American Depositary Shares (“ADSs”) of Reckitt Benckiser Group PLC (OTC: RBGLY) between January 13, 2021 through July 28, 2024, both dates inclusive (the “Class Period”), of the important August 4, 2025 lead plaintiff deadline.
NEW YORK, June 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Reckitt Benckiser Group Plc (“Reckitt” or the “Company”)(OTCMKTS: RBGLY). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
NEW YORK CITY and NEW ORLEANS, June 17, 2025 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until August 4, 2025 to file lead plaintiff applications in a securities class action lawsuit against Reckitt Benckiser Group PLC (“Reckitt” or the “Company”) (OTC: RBGLY), if they purchased the Company’s American Depositary Shares (“ADSs”) between January 13, 2021 and July 28, 2024, inclusiv...
NEW YORK, June 16, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Reckitt Benckiser Group plc (OTC:RBGLY), UroGen Pharma Ltd. (NASDAQ:URGN), Red Cat Holdings, Inc. (NASDAQ: RCAT) and Fortrea Holdings Inc. (NASDAQ:FTRE). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case...
NEW YORK, June 08, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of American Depositary Shares (“ADSs”) of Reckitt Benckiser Group PLC (OTC: RBGLY) between January 13, 2021 through July 28, 2024, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than August 4, 2025.
Robbins LLP is Investigating Allegations that Reckitt Benckiser Group PLC (RBGLY) Misled Investors Regarding the Safety of its Enfamil Baby Formula
Here is how Reckitt Benckiser Group PLC (RBGLY) and Reeds (REED) have performed compared to their sector so far this year.
Reckitt Benckiser Group (RBGLY) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the companys earnings prospects. This might drive the stock higher in the near term.
Does Reckitt Benckiser Group PLC (RBGLY) have what it takes to be a top stock pick for momentum investors? Lets find out.
Abbott Laboratories and Reckitt Benckiser Group Plc shares fell as a judge ordered a new trial after rejecting a verdict that had cleared the companies of liability over claims they hid potential risks of their premature-infant formulas.
The Top 10 Players Dominating Revenues are Reckitt Benckiser Group PLC, S.C. Johnson & Son, Inc., Church & Dwight Co. Inc., Scholls Wellness Co., Puma SE, Sanofi SA, Blistex Incorporated, Chattem, Inc., Rocket Pure, and Guangzhou Bubujie Household Products Co. Ltd. The Top 10 Players Dominating Revenues are Reckitt Benckiser Group PLC, S.C. Johnson & Son, Inc., Church & Dwight Co. Inc., Scholls Wellness Co., Puma SE, Sanofi SA, Blistex Incorporated, Chattem, Inc., Rocket Pure, and Guangzhou Bu...
Dublin, Nov. 25, 2024 (GLOBE NEWSWIRE) -- The "Stain Remover Products Market Size, Share and Trends Analysis Report by Product, Application (Household, Commercial), Distribution Channel (Offline, Online), and Region 2024-2030" report has been added to ResearchAndMarkets.coms offering.The global stain remover products market size is expected to reach USD 31.32 billion by 2030, registering to grow at a CAGR of 5.1% from 2024 to 2030
Shares of Reckitt Benckiser Group Plc jumped the most in 24 years following a US jury verdict that cleared it and Abbott Laboratories over claims they hid potential risks of their premature-infant formulas.
Reckitt Benckiser Plc sales fell less than expected, offering limited relief for investors concerned about US lawsuits over its formula for premature babies.
Reckitt Benckiser Group PLC (LSE:RKT, ETR:3RB) could return up to £12.5 billion to shareholders, about 40% of its market value, as part of a major strategic...
Reckitt Benckiser Group Plc has started early discussions with some of the potential suitors for its homecare assets, which could fetch more than £6 billion ($7.9 billion) in a deal, according to people familiar with the matter.
The Global Medical Foods Market Size Was Valued at USD 24.73 Billion in 2023 and the Worldwide Medical Foods Market Size is Expected to Reach USD 49.73 Billion by 2033, according to a research report published by Spherical Insights & Consulting. Companies covered: Danone, Nestlé, Abbott, Targeted Medical Pharma Inc., Primus Pharmaceuticals Inc., Fresenius Kabi AG, Mead Johnson & Company, LLC, Friso, Morinaga Milk Industry, Medtrition, Inc., Metagenics LLC, Reckitt Benckiser Group PLC, Alfasigma ...
The Global Mother and Child Healthcare Market Size was Valued at USD 723.67 Billion in 2023 and the Worldwide Global Mother and Child Healthcare Market Size is Expected to Reach USD 2106.78 Billion by 2033, according to a research report published by Spherical Insights & Consulting. Companies Covered: Johnson & Johnson Private Limited, Siemens, Fuji Latex Co, Okamoto Industries Inc., Agile Therapeutics, SYNAPSE Product Development, RAND Corporation, McKinsey & Company, Reckitt Benckiser Group Pl...
Reckitt Benckiser Group PLC (LSE:RKT, ETR:3RB) shares tumbled 7.5% on Monday morning after a litigation decision in the US against Abbott Laboratories...